SCHEMBL3788554

SCHEMBL3788554

CCOCN(COC)S(=O)(=O)c1ccccc1-c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 5/20 0.37
FEN1 P39748 5/20 0.37
L3MBTL1 Q9Y468 1/20 0.35
OPRM1 P35372 2/20 0.34
OPRK1 P41145 2/20 0.34
EDNRA P25101 2/20 0.33
PTGS2 P35354 1/20 0.33
GSTO1 P78417 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
EDNRB P24530 1/20 0.32
CASP1 P29466 1/20 0.32
AKR1B1 P15121 1/20 0.32
PTPN1 P18031 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7849847 0.88 ALOX5AP (0.36) ALOX5APFEN1L3MBTL1OPRM1OPRK1
SCHEMBL9307372 0.78 ALOX5AP (0.52) ALOX5APFEN1L3MBTL1ALDH1A1HTT
Ether SCHEMBL8368264 0.72 CASP1 (0.40) L3MBTL1EDNRAPTGS2ALDH1A1EDNRB
SCHEMBL15924800 0.70 ALOX5AP (0.52) ALOX5APFEN1OPRM1OPRK1PTGS2
SCHEMBL9306541 0.69 ALOX5AP (0.57) ALOX5APFEN1OPRM1OPRK1PTGS2
SCHEMBL27500425 0.69 ALDH1A1 (0.38) ALOX5APFEN1OPRM1OPRK1EDNRA
SCHEMBL2704655 0.67 PSIP1 (0.50) ALOX5APFEN1EDNRAPTGS2ALDH1A1
SCHEMBL10958463 0.67 CASP1 (0.41) ALOX5APFEN1L3MBTL1OPRM1OPRK1
SCHEMBL6698432 0.66 ALOX5AP (0.58) ALOX5APFEN1OPRM1OPRK1EDNRA
SCHEMBL10782653 0.66 ALOX5AP (0.44) ALOX5APFEN1OPRM1OPRK1EDNRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010114801-A1 ORAL FORMULATIONS OF DIPHENYLSULFONAMIDE ENDOTHELIN AND ANGIOTENSIN II RECEPTOR AGONISTS TO TREAT ELEVATED BLOOD PRESSURE AND DIABETIC NEPHROPATHY LIGAND PHARMACEUTICALS INC. (US) 2010-10-07 WO disclosed